glp-1 obesity drug news today september 15 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Study Shows 85% Of Patients

Improper reconstitution Shaking the vial, using non-sterile technique, or reconstituting with the wrong type or volume of water are errors that compromise the entire vial

Effects of short and long term treatment of Ballota undulata on female albino rats fertility and pregnancy

Benefits Darker tan with less exposure to UV radiation Tanning without sunburn, even for fair-skinned individuals Possible reduction in the risk of Melanoma (skin cancer) Possible reduction in the incidence of sun-damaged skin Possible reduction in body fat No sunburn or tan lines No sunless tanning streaks or fake tan removal Possible increase in libido During clinical trials for its use as a tanning agent, melanotan II was found to be a potent stimulator of male erections

President Donald Trump's repeated description of GLP-1 medications as "fat shots," "fat drugs" and "fat pills" has renewed debate over how weight-loss medicines are portrayed, with doctors warning that the labels oversimplify drugs now used to treat a range of chronic conditions